Medicated Skin Care in Japan
Euromonitor International's Medicated Skin Care in Japan market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 51 | Publication date: May 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Acne treatments; Antiparasitics/lice (head and body) treatments; Antipruritics; Child-specific medicated skin care; Emollients/therapeutic moisturisers; Haemorrhoid treatments; Hair loss treatments; Lip care treatments; Medicated shampoos; Nappy (diaper) rash treatments; Topical allergy remedies/antihistamines; Topical antifungals; Topical germicidals/antiseptics; Vaginal antifungals
Table of contents
MEDICATED SKIN CARE IN JAPAN : MARKET INSIGHT
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 1 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 2 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 3 Herbal vs Standard Medicated Skin Care 2003-2008
Table 4 Acne Treatments by Format: % Value Breakdown 2004-2008
Table 5 Medicated Skin Care Company Shares by Value 2004-2008
Table 6 Medicated Skin Care Brand Shares by Value 2005-2008
Table 7 Acne Treatments Brand Shares by Value 2005-2008
Table 8 Hair Loss Treatments Brand Shares by Value 2005-2008
Table 9 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 10 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
LOCAL COMPANY PROFILES - JAPAN
DAIICHI SANKYO CO LTD - OTC HEALTHCARE - JAPAN
STRATEGIC DIRECTION
KEY FACTS
Summary 1 Daichi Sankyo Co Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 2 DaiichiSankyo Group: Competitive Position 2008
EISAI CO LTD - OTC HEALTHCARE - JAPAN
STRATEGIC DIRECTION
KEY FACTS
Summary 3 Eisai Co Ltd: Key Facts
Summary 4 Eisai Co Ltd: Operational Indicators
PRODUCTION
COMPETITIVE POSITIONING
Summary 5 Eisai Co Ltd: Competitive Position 2008
HISAMITSU PHARMACEUTICAL CO INC - OTC HEALTHCARE - JAPAN
STRATEGIC DIRECTION
KEY FACTS
Summary 6 Hisamitsu Pharmaceutical Co Inc: Key Facts
Summary 7 Hisamitsu Pharmaceutical Co Inc: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 8 Hisamitsu Pharmaceutical Co Inc: Competitive Position 2008
LION CORP - OTC HEALTHCARE - JAPAN
STRATEGIC DIRECTION
KEY FACTS
Summary 9 Lion Corp: Key Facts
Summary 10 Lion Corp: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 11 Lion Corp: Competitive Position 2008
MIKI CORP - OTC HEALTHCARE - JAPAN
STRATEGIC DIRECTION
KEY FACTS
Summary 12 Miki Corp: Key Facts
COMPANY BACKGROUND
PRODUCTION
Summary 13 Miki Corp: Production Statistics 2008
COMPETITIVE POSITIONING
Summary 14 Miki Corp: Competitive Position 2008
ROHTO PHARMACEUTICAL CO LTD - OTC HEALTHCARE - JAPAN
STRATEGIC DIRECTION
KEY FACTS
Summary 15 Rohto Pharmaceutical Co Ltd: Key Facts
Summary 16 Rohto Pharmaceutical Co Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 17 Rohto Pharmaceutical Co Ltd: Competitive Position 2008
SAHTO PHARMACEUTICAL CO LTD - OTC HEALTHCARE - JAPAN
STRATEGIC DIRECTION
KEY FACTS
Summary 18 Sato Pharmaceutical Co Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 19 Sato Pharmaceutical Co Ltd: Competitive Position 2008
SSP CO LTD - OTC HEALTHCARE - JAPAN
STRATEGIC DIRECTION
KEY FACTS
Summary 20 SSP Co Ltd: Key Facts
Summary 21 SSP Co Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 22 SSP Co Ltd: Competitive Position 2008
TAISHO PHARMACEUTICAL CO LTD - OTC HEALTHCARE - JAPAN
STRATEGIC DIRECTION
KEY FACTS
Summary 23 Taisho Pharmaceutical Co Ltd: Key Facts
Summary 24 Taisho Pharmaceutical Co Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 25 Taisho Pharmaceutical Co Ltd: Competitive Position 2008
TAKEDA CHEMICAL INDUSTRIES LTD - OTC HEALTHCARE - JAPAN
STRATEGIC DIRECTION
KEY FACTS
Summary 26 Takeda Chemical Industries Ltd: Key Facts
Summary 27 Takeda Chemical Industries Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 28 Takeda Chemical Industries Ltd: Competitive Position 2008
OTC HEALTHCARE IN JAPAN
EXECUTIVE SUMMARY
Maturity produces slow growth
Government encourages self-medication
Domestic companies dominate
Distribution remains restricted
Shrinking sales over the forecast period
KEY TRENDS AND DEVELOPMENTS
Demographic changes shape consumer demand
Government focuses on reducing medical costs
Men’s health
Strong players face challenges through mergers
Distribution on the brink of expansion
MARKET INDICATORS
Table 11 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 12 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 13 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 14 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 15 OTC Healthcare Company Shares by Value 2004-2008
Table 16 OTC Healthcare Brand Shares by Value 2005-2008
Table 17 Penetration of Private Label by Sector 2003-2008
Table 18 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 19 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 20 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 21 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Self-medication and preventative medicine
Generics
Switches
Summary 29 OTC Healthcare Switches 2005-2008
DEFINITIONS
Summary 30 Research Sources